Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Antiflatulent Agent	NCIT_C29738	[Natural or synthetic compounds usually administered orally, Antiflatulent Agents relieve or prevent flatulence, excess gas in the stomach and intestines, by adsorbing the gas, stimulating intestinal elimination of gas, or preventing gas formation. Alpha-galactosidase and activated charcoal are used against flatulence. (NCI04)]
Grade 5 General Disorders and Administration Site Conditions - Other, Specify, CTCAE	NCIT_C146327	[Death]
General Disorders and Administration Site Conditions - Other, Specify, CTCAE	NCIT_C143513
Grade 5 Glossopharyngeal Nerve Disorder, CTCAE	NCIT_C146328	[Death]
Glossopharyngeal Nerve Disorder, CTCAE	NCIT_C143518	[A disorder characterized by dysfunction of the glossopharyngeal nerve (ninth cranial nerve).]
Grade 5 Glucose Intolerance, CTCAE	NCIT_C146329	[Death]
Glucose Intolerance, CTCAE	NCIT_C143519	[A disorder characterized by an inability to properly metabolize glucose.]
Malignant Vascular Neoplasm	NCIT_C7390	[A malignant neoplasm arising from the vascular tissue. It is characterized by vascular channel formation and malignant endothelial cells.]
Malignant Cardiovascular Neoplasm	NCIT_C114940	[A primary or metastatic malignant neoplasm involving the cardiovascular system.]
Stage I Nasopharyngeal Carcinoma AJCC v6	NCIT_C7395	[Stage I includes: T1, N0, M0. T1: Tumor confined to the nasopharynx. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.)]
Nasopharyngeal Carcinoma by AJCC v6 Stage	NCIT_C90522	[A term that refers to the staging of nasopharyngeal carcinoma according to the American Joint Committee on Cancer, 6th edition.]
LM Mouse	NCIT_C15100
Stage III Nasopharyngeal Carcinoma AJCC v6	NCIT_C7396	[Stage III includes: (T1, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N0, M0); (T3, N1, M0); (T3, N2, M0). T3: Tumor involves bony structures and/or paranasal sinuses. N2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. M0: No distant metastasis. (AJCC 6th ed.)]
MM Mouse	NCIT_C15101
Grade 5 Gastric Perforation, CTCAE	NCIT_C146320	[Death]
Gastric Perforation, CTCAE	NCIT_C143502	[A disorder characterized by a rupture in the stomach wall.]
Stage IV Nasopharyngeal Carcinoma AJCC v6	NCIT_C7397	[Stage IV includes: IVA: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0); IVB (Any T, N3, M0); IVC (Any T, Any N, M1). T4: Tumor with intracranial extension and/or involvement of cranial nerves, infratemporal fossa, hypopharynx, orbit, or masticator space. N3: Metastasis in a lymph node(s). N3a: greater than 6 cm in dimension. N3b: extension to the supraclavicular fossa. M1: Distant metastasis. (AJCC 6th ed.)]
Albino Mice, NZ Pet Shop, 1948	NCIT_C15102
Grade 5 Gastric Stenosis, CTCAE	NCIT_C146321	[Death]
Gastric Stenosis, CTCAE	NCIT_C143503	[A disorder characterized by a narrowing of the lumen of the stomach.]